Feed Top Reports Pricing

⌘K

00:15:13·1204d

SECFiling

SEC Form EFFECT filed by Oyster Point Pharma Inc.

OYST· Oyster Point Pharma Inc.

Health Care

Original source

Companies

OYST
Oyster Point Pharma Inc.
Health Care

Recent analyst ratings

Aug 11UpdateChardan Capital Markets$22.00
Jul 18UpdateH.C. Wainwright$20.00
Nov 9UpdateJP Morgan$23.00

Related

NEWS792d
Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7
13D/G1164d
SEC Form SC 13G/A filed by Oyster Point Pharma Inc. (Amendment)
13D/G1164d
SEC Form SC 13G/A filed by Oyster Point Pharma Inc. (Amendment)
SEC1196d
SEC Form 15-12G filed by Oyster Point Pharma Inc.
SEC1196d
Oyster Point Pharma Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits (Amendment)
13D/G1196d
SEC Form SC 13D/A filed by Oyster Point Pharma Inc. (Amendment)
13D/G1200d
SEC Form SC 13D/A filed by Oyster Point Pharma Inc. (Amendment)
13D/G1204d
SEC Form SC 13D/A filed by Oyster Point Pharma Inc. (Amendment)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022